Results 71 to 80 of about 14,712 (219)
Rational use of the fluoroquinolones
The systemic fluoroquinolones (FQs) have recently been reported to be associated with significant side-effects in susceptible individuals. This has prompted the Food and Drug Administration (FDA) in the USA and the European Medicines Agency (EMA) to issue warnings regarding their use.
Richards, G A, Brink, A J, Feldman, C
openaire +3 more sources
Abstract Background Limited evidence exists regarding the impact of baseline functional and cognitive impairments on the outcomes of patients with pneumonia. Methods We used medical and long‐term care administrative databases in a prefecture in Japan that contained care need levels assessed using the national standardized certification system.
Jumpei Taniguchi+6 more
wiley +1 more source
Abstract Background Acute uncomplicated cystitis (AUC) is a urinary tract infection and is generally treated using antimicrobial therapy. Escherichia coli is the main causative agent of AUC. Recently, the prevalence of fluoroquinolone (FQ)‐resistant‐E. coli has demonstrated a noticeable increase. In this study, we aimed to investigate the effectiveness
Takuhisa Nukaya+2 more
wiley +1 more source
This study details a scalable process for synthesizing quaternary ammonium compounds (QACs) from linear polyglycerols using gaseous chloromethane. The resulting compounds demonstrate effective antibacterial and antibiofilm properties against drug‐resistant S.
Natalie Hanheiser+5 more
wiley +1 more source
Ciprofloxacin, an antibiotic with cardiac actions on isolated rat hearts [PDF]
Context: Ciprofloxacin is the most commonly used fluoroquinolone and is prescribed as the antibiotic of choice in the treatment of several microbial infections.
Loipa Galán-Martínez+3 more
doaj
Fluoroquinolones and aortic aneurysms: Which fluoroquinolones are at risk?
A recent cohort study described a 66% increased rate of aortic aneurysms in patients receiving fluoroquinolones (Pasternak et al. BMJ 2018; 360:k678). The authors did not study the different fluoroquinolones. The present study was performed to investigate the fluoroquinolones more at risk of aortic aneurysms.
Vanessa Rousseau+6 more
openaire +2 more sources
ABSTRACT Introduction Infection causes significant morbidity and mortality in pediatric acute myeloid leukemia (pAML). This study describes the incidence and risk factors of bloodstream infection (BSI) and invasive fungal infection (IFI) in pAML. Methods A retrospective chart review was performed of patients treated according to the ANLL‐97/AML‐12 (N =
Emily R. Schwartz+13 more
wiley +1 more source
Abstract Introduction Treatment of infections in patients with burn injuries is challenging due to altered antimicrobial pharmacokinetics. Continuous infusion β‐lactam therapy may be a useful antimicrobial stewardship strategy to improve pharmacodynamic target attainment in this population.
Jay D. Olivet+8 more
wiley +1 more source
Guilian Li,1,* Qian Guo,1,2,* Haican Liu,1 Li Wan,1 Yi Jiang,1 Machao Li,1 Li-li Zhao,1 Xiuqin Zhao,1 Zhiguang Liu,1 Kanglin Wan1 1State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and ...
Li G+9 more
doaj
Abstract Objective To investigate the risk of aortic aneurysm or dissection associated with fluoroquinolone (FQ) prescription compared to macrolides in German routine health care data in order to replicate the recent study (Pharmacotherapy 2023;43:883) extending the results by contributing evidence for six additional broad‐spectrum antibiotic classes ...
Julia Wicherski+8 more
wiley +1 more source